COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia

Leukemia. 2021 Sep;35(9):2703-2705. doi: 10.1038/s41375-021-01270-w. Epub 2021 May 13.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • Adult
  • Aged
  • BNT162 Vaccine
  • COVID-19 / immunology
  • COVID-19 / pathology
  • COVID-19 / virology
  • COVID-19 Drug Treatment*
  • COVID-19 Vaccines / immunology
  • COVID-19 Vaccines / therapeutic use*
  • Female
  • Humans
  • Immunity
  • Immunocompromised Host
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Leukemia, Lymphocytic, Chronic, B-Cell / virology
  • Male
  • Middle Aged
  • SARS-CoV-2 / drug effects*
  • SARS-CoV-2 / immunology

Substances

  • COVID-19 Vaccines
  • 2019-nCoV Vaccine mRNA-1273
  • BNT162 Vaccine